The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Pediatric Malignant Peripheral Nerve Sheath Tumor: The Italian and German Soft Tissue Sarcoma Cooperative Group
Open accessAbstract
Purpose: To assess the value of chemotherapy and radiotherapy in children with malignant peripheral nerve sheath tumors (MPNSTs) and to identify risk factors associated with outcome. Patients and Methods: A total of 167 untreated eligible patients enrolled onto the Italian and German studies between 1975 and 1998 entered this analysis. Seventeen percent of patients had neurofibromatosis type 1 (NF1). Chemotherapy was administered to 74% of patients; radiotherapy was administered to 38% of patients. Results: With a median follow-up of 7 years, 5-year overall survival (OS) and progression-free survival (PFS) were 51% and 37%, respectively. The 5-year OS and PFS by Intergroup Rhabdomyosarcoma Study (IRS) groupings were as follows: group I, 82% and 61%; group II, 62% and 37%; group III, 32% and 27%; group IV, 26% and 21%, respectively. Univariate analysis identified IRS groups, size, invasiveness, primary site, age, and presence of NF1 as prognostic factors; multivariate analysis identified absence of NF1, tumor invasiveness T1, IRS groups I to II and extremity of primary site as independent favorable factors for OS. A trend was observed toward a benefit from radiotherapy after initial gross resection. The overall response rate to primary chemotherapy, including minor responses, in group III patients was 45%. Conclusion: MPNST is an aggressive tumor for which complete surgical resection is the mainstay of successful treatment. Postoperative radiotherapy may have a role in improving local control in patients with minimal residual tumor. The reported responses to primary chemotherapy suggest that it may be effective in patients with tumor considered unresectable at diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Practical Nonparametric Statistics
Groggel, D. J. (2000) · Technometrics · doi:10.1080/00401706.2000.10486067 · Cited by 11,041
Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases
Ducatman, B. S., Scheithauer, B. W., Piepgras, D. G., Reiman, H. M., & Ilstrup, D. M. (1986) · Cancer · doi:10.1002/1097-0142(19860515)57:10<2006::aid-cncr2820571022>3.0.co;2-6 · Cited by 1,581
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
Evans, D. G. R., Baser, M. E., McGaughran, J., Sharif, S., Howard, E., & Moran, A. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.5.311 · Cited by 1,282
Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases
Hruban, R. H., Shiu, M. H., Senie, R. T., & Woodruff, J. M. (1990) · Cancer · doi:10.1002/1097-0142(19900915)66:6<1253::aid-cncr2820660627>3.0.co;2-r · Cited by 366
D'Agostino, A. N., Soule, E. H., & Miller, R. H. (1963) · Cancer · doi:10.1002/1097-0142(196308)16:8<1015::aid-cncr2820160808>3.0.co;2-i · Cited by 365
Soft tissue sarcomas of childhood
Meyer, W. H., & Spunt, S. L. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.11.001 · Cited by 169
Molecular and cytogenetic analysis of tumors in von recklinghausen neurofibromatosis
Glover, T. W., Stein, C. K., Legius, E., Andersen, L. B., Brereton, A., & Johnson, S. (1991) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870030111 · Cited by 145
Ferrari, A., Casanova, M., Collini, P., Meazza, C., Luksch, R., Massimino, M., Cefalo, G., Terenziani, M., Spreafico, F., Catania, S., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.053 · Cited by 138
Self-citationInfections in children with cancer: a continued need for the comprehensive physical examination.
Casanova, M., Ferrari, A., Spreafico, F., Luksch, R., Terenziani, M., Cefalo, G., Massimino, M., Gandola, L., Lombardi, F., & Fossati-Bellani, F. (1999) · PubMed · Cited by 98
Self-citationExtremity malignant peripheral nerve sheath tumors (neurogenic sarcomas): A 10-year experience
Vauthey, J., Woodruff, J. M., & Brennan, M. F. (1995) · Annals of Surgical Oncology · doi:10.1007/bf02303627 · Cited by 96
Malignant Peripheral Nerve Sheath Tumors in Children
Casanova, M., Ferrari, A., Spreafico, F., Luksch, R., Terenziani, M., Cefalo, G., Massimino, M., Gandola, L., Lombardi, F., & Fossati‐Bellani, F. (1999) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199911000-00011 · Cited by 57
Self-citation(1988) · doi:10.1002/1097-0142(19880115)61:2<209::aid-cncr2820610202>3.0.co;2-l
Cited by
Gutmann, D. H., Ferner, R. E., Listernick, R. H., Korf, B. R., Wolters, P. L., & Johnson, K. J. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.4 · Cited by 862
Neurofibromatosis Type 1 Revisited
Williams, V. C., Lucas, J., Babcock, M. A., Gutmann, D. H., Korf, B., & Maria, B. L. (2009) · Pediatrics · doi:10.1542/peds.2007-3204 · Cited by 695
Neurofibromatosis type 1: a multidisciplinary approach to care
Hirbe, A. C., & Gutmann, D. H. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70063-8 · Cited by 626
Romaguera, J. E., Fayad, L., Rodriguez, M. A., Broglio, K. R., Hagemeister, F. B., Pro, B., McLaughlin, P., Younes, A., Samaniego, F., Goy, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.1825 · Cited by 557
A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor
Ratner, N., & Miller, S. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3911 · Cited by 493
Metadata
- Authors
- Carli, M., Ferrari, A., Mattke, A., Zanetti, I., Casanova, M., Bisogno, G., Cecchetto, G., Alaggio, R., De Sio, L., Koscielniak, E., Sotti, G., & Treuner, J.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-11-20
- Volume
- 23
- Issue
- 33
- Pages
- 8422-8430
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2147361937
- Cited by
- 371
- References
- 16
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.